Literature DB >> 19466581

Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals.

Wendy McKinnon1, Kimberly C Banks, Joan Skelly, Wendy Kohlmann, Robin Bennett, Kristen Shannon, Joy Larson-Haidle, Taka Ashakaga, Jeffrey N Weitzel, Marie Wood.   

Abstract

Many individuals do not proceed with cancer predisposition testing due to fears of genetic discrimination (GD). We report the results of a survey of 47 unaffected, mutation positive individuals regarding insurance outcomes. Participants recruited from six different Cancer Risk Programs across the country were queried about their experiences with health, life, and disability insurance, as well as employment issues. Eighty-seven percent of participants carried a BRCA mutation and 87% were part of a group insurance plan at the time of testing. Forty-seven percent of participants self-paid for testing. Less than 10% of participants reported that their results were placed in the general medical record, while 43% did not know where their results were placed. Due to concerns about GD, 13% of participants stated they avoided changing jobs. Thirteen percent stated that their at-risk relatives had not undergone testing for the familial mutation due to fears about GD. Adverse events following genetic testing included two denials from private health insurers, one denial for average life insurance coverage and one denial for additional disability insurance. There were no reports of job discrimination. Results suggest fear of GD is prevalent, yet data do not support evidence that GD exists.

Entities:  

Mesh:

Year:  2009        PMID: 19466581      PMCID: PMC3528358          DOI: 10.1007/s10689-009-9248-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Coding for change: the power of the human genome to transform the American Health Insurance System.

Authors:  Jennifer S Geetter
Journal:  Am J Law Med       Date:  2002

2.  Likelihood of undergoing genetic testing for cancer risk: a population-based study.

Authors:  K Bosompra; B S Flynn; T Ashikaga; C J Rairikar; J K Worden; L J Solomon
Journal:  Prev Med       Date:  2000-02       Impact factor: 4.018

3.  Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients.

Authors:  S Taylor; S Treloar; K Barlow-Stewart; M Stranger; M Otlowski
Journal:  Clin Genet       Date:  2008-05-19       Impact factor: 4.438

4.  An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

Authors:  H T Lynch; P Watson; S Tinley; C Snyder; C Durham; J Lynch; Y Kirnarsky; O Serova; G Lenoir; C Lerman; S A Narod
Journal:  Cancer Genet Cytogenet       Date:  1999-03

5.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.

Authors:  Emily A Peterson; Kara J Milliron; Karen E Lewis; Susan D Goold; Sofia D Merajver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

7.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

8.  Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians.

Authors:  Katrina J Lowstuter; Sharon Sand; Kathleen R Blazer; Deborah J MacDonald; Kimberly C Banks; Carol A Lee; Barbara U Schwerin; Margaret Juarez; Gwen C Uman; Jeffrey N Weitzel
Journal:  Genet Med       Date:  2008-09       Impact factor: 8.822

9.  Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients.

Authors:  Kira A Apse; Barbara B Biesecker; Francis M Giardiello; Barbara P Fuller; Barbara A Bernhardt
Journal:  Genet Med       Date:  2004 Nov-Dec       Impact factor: 8.822

10.  Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Authors:  Timothy R Rebbeck; Noah D Kauff; Susan M Domchek
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

View more
  4 in total

Review 1.  Global trends on fears and concerns of genetic discrimination: a systematic literature review.

Authors:  Annet Wauters; Ine Van Hoyweghen
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

2.  Study protocol: the Australian genetics and life insurance moratorium-monitoring the effectiveness and response (A-GLIMMER) project.

Authors:  Louise Keogh; Paul Lacaze; Jane Tiller; Aideen McInerney-Leo; Andrea Belcher; Tiffany Boughtwood; Penny Gleeson; Martin Delatycki; Kristine Barlow-Stewart; Ingrid Winship; Margaret Otlowski
Journal:  BMC Med Ethics       Date:  2021-05-21       Impact factor: 2.652

Review 3.  Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.

Authors:  Aideen M McInerney-Leo; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-19       Impact factor: 5.555

Review 4.  Genetic discrimination and life insurance: a systematic review of the evidence.

Authors:  Yann Joly; Ida Ngueng Feze; Jacques Simard
Journal:  BMC Med       Date:  2013-01-31       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.